To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Mandated by the Inflation Reduction Act of 2022, the US government is negotiating with pharmaceutical companies over the 'maximum fair price' of ten drugs widely used by Medicare patients. The pharmaceutical companies contend that a 'fair' price is a 'value-based price' that enables their shareholders to capture the value the drug creates for society and warn that lowering drug prices will reduce investments in new drugs. This Element responds to these arguments by showing that pharmaceutical companies (a) should have their drug prices regulated, given scale economies in supplying drugs and price inelasticity of drug demand; (b) use their profits from unregulated drug prices to distribute cash dividends and stock buybacks to shareholders; (c) do not typically rely upon investment by shareholders to fund drug innovation; and (d) benefit from 'collective and cumulative learning' in foundational and translational research that is antecedent and external to their investments in clinical research.
The ownership of firms is mediated by financial assets in a corporate economy. The Modigliani-Miller theorem and most macroeconomic models tend to play down the relevance of this financial mediation. Behavioral and institutional factors make it unlikely, however, that households ‘pierce the corporate veil’ and adjust their portfolios to offset changes in firms’ financial decisions and, as shown by (an extended version of) Kaldor’s ‘neo-Pasinetti theorem’, households as a group cannot declare their own dividends by selling shares if corporate retained earnings are raised. As a result, aggregate saving rates will be increasing in the share of profits, the retention rate out of profits, and the share of stock buybacks. Changes in household portfolio behavior also affect aggregate saving, but the direction depends on firms’ retention and buyback policies. In this setting, a tightening of credit constraints can lead to a protracted decline in aggregate demand, feedback effects from capital gains to portfolio choice can fuel stock market bubbles, and Tobin’s q becomes a poor indicator of the return to additional capital.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.